Cosmetic Peat Institute
ET

Research

This section covers the scientific and clinical evidence underpinning the use of peat in cosmetics and dermatology. Peat research spans over a century and is concentrated in Central and Eastern Europe, where balneotherapy has the strongest clinical tradition.

Overview of the evidence base

Research on cosmetic peat can be grouped into several areas:

Anti-inflammatory effects

Peat’s most clinically documented property is its anti-inflammatory action. Studies have demonstrated that humic acids — the main bioactive fraction of decomposed peat — inhibit key inflammatory mediators including prostaglandins and cytokines. This underpins peat’s use in conditions such as psoriasis, eczema, and seborrhoeic dermatitis.

Anti-inflammatory effects

Effects on skin microbiome

Emerging research suggests that the complex microbial ecosystem preserved in Sphagnum peat may interact beneficially with the human skin microbiome. The antimicrobial and prebiotic properties of humic substances are an active area of investigation.

Peat and the microbiome

Mineral composition and skin nutrition

Peat is a natural reservoir of trace minerals — iron, zinc, copper, manganese, and others — in forms that may be bioavailable through dermal absorption. Mineral analysis studies have mapped these concentrations in commercially relevant peat deposits.

Mineral composition

Keratolytic effects

Certain organic acids in peat — including fulvic acids and low-molecular-weight humic fractions — have shown mild keratolytic (skin-softening) activity, relevant to scaling conditions such as psoriasis and keratosis pilaris.

Keratolytic effects

Safety research

Independent safety assessments have examined peat for heavy metals, polycyclic aromatic hydrocarbons (PAHs), and microbiological contaminants. Standards vary by country; the EU cosmetics framework provides the regulatory ceiling.

Safety

Research limitations

The evidence base for peat therapy has several limitations:

  • Most studies are small-scale or observational
  • Many were published before modern clinical trial standards
  • Publication bias towards positive results is likely
  • Much research exists only in non-English languages

We present the evidence as accurately as possible while noting these limitations throughout.

Key researchers and institutions

Peat therapy research has been led by institutions in Germany (Bad Elster, Bad Kissingen), Czech Republic, Austria, Finland, and Estonia. Key figures include researchers at the Estonian University of Life Sciences and the Institute of Chemistry at the University of Tartu.